Concurrent Food Expo features “Multi-Facets of Chinese Medicine” exhibition

HONG KONG SAR - Media OutReach Newswire - 20 July 2026 - The 25^th International Conference of the Modernization of Chinese Medicine and Health Products (ICMCM), organised by the Modernized Chinese Medicine International Association (MCMIA) together with the HKTDC and ten scientific research institutions, will be held from 13 to 15 August at the Hong Kong Convention and Exhibition Centre (HKCEC), offering industry professionals the latest insights into Chinese medicine. This year's conference is funded by the Chinese Medicine Development Fund of the Government of the Hong Kong Special Administrative Region. It is dedicated to strengthening the ties between Hong Kong's Chinese medicine industry and the international market, while promoting Hong Kong's leading role in the global field of Chinese medicine. Register for the conference to stay updated with the latest industry information on Chinese medicine:https://tinyurl.com/tmvryr38Aligning with the strategic Blueprint with a focus on "Bringing In and Going Global" The Chinese Medicine Development Blueprint of Hong Kong (the Blueprint) released in 2025 positions Hong Kong as a bridgehead for the global internationalisation of Chinese medicine and a key highland within the national framework for Chinese medicine development. To actively support the strategic direction of the Blueprint, this year's conference adopts the theme Clinical Translation, Regulatory Policies and Global Innovative Pathways of Traditional Medicine, focusing on two core elements: bringing in and going global. It introduces Hong Kong's Chinese medicine regulations and resource support to participants from Chinese Mainland and overseas, while inviting overseas regulatory authorities to share their local traditional medicine regulations. This year, some 30 experts and scholars from Hong Kong, Chinese Mainland, and overseas have been invited to comprehensively explore the latest research and development trends, regulatory interpretations, and success cases in Chinese medicine. The three-day conference is divided into five major thematic sessions, covering policy blueprints, international regulations, clinical research, success case sharing, and talent cultivation: To help enterprises from Chinese Mainland and abroad understand Hong Kong's Chinese medicine regulation and support, Dr. Vincent Chung Chi-ho, Commissioner for Chinese Medicine Development, Chinese Medicine Unit, Health Bureau, will elaborate on the Blueprint, while Law Kwok-wai, Robert, Chief Pharmacist (Chinese Medicine), Chinese Medicine Regulatory Office, Department of Health, Dr. Yeung Kin Wai, Senior Chemist, Government Chinese Medicines Testing Institute, Department of Health, and Prof. Bian Zhaoxiang, Hospital Chief Executive, The Chinese Medicine Hospital of Hong Kong (CMHHK) , will share in-depth insights into the latest progress in Chinese medicine regulation, quality standards testing, and clinical practice and research at the Chinese Medicine Hospital. Furthermore, Arnold Lau, Associate Director-General, Invest Hong Kong, Dr. William Cheung, Deputy Chief Manager (Life and Health Technology), Office for Attracting Strategic Enterprises (OASES), Angela Yu, Deputy Head of Health Tech and TCM, Hong Kong Productivity Council and Wing Chu, Deputy Director of Research, HKTDC, will participate in a panel discussion to analyse the Hong Kong government's resource support for the development of Chinese medicine. To provide attendees with a comprehensive analysis of market trends, Prof. Zheng Linyun, Executive Vice President of the Shanghai Academy of International Standardization of Traditional Chinese Medicine, will share reflections and prospects on the transformation of ISO/TC249. Furthermore, Prof. Taruna Ikrar, Chairperson of the Indonesian Food and Drug Authority (BPOM), Indonesia, Nurul Anisah Binti Shahri from National Pharmaceutical Regulatory Agency (NPRA), Ministry of Health, Malaysia and Thawatchai Nakkaratniyom, Senior Professional Level Pharmacist, Head of Pre-marketing Control Group, Herbal Products Division at Thai Food and Drug Administration, Ministry of Public Health, Thailand will jointly analyse the regulations and standards of the Southeast Asian market. Scientific and clinical experts will share the latest progress in the scientific research and clinical application of Chinese medicine, as well as experiences regarding the R&D application and clinical efficacy of hospital-made Chinese medicine preparations. Prof. Zhang Zhongde, Deputy President of Guangzhou University of Chinese Medicine & President of Guangdong...